Recombinant human IL-31 protein - Bioactive cytokine

Recombinant cytokine, source: E. coli

ABOUT

Human IL-31 protein - E. coli-expressed, tag-free, carrier-free

Recombinant human IL-31 is a high-quality and biologically active cytokine, validated using proprietary IL-31 reporter cells. This member of the IL-6/gp130 family is produced in E. coli and thoroughly purified to remove endotoxins.

Recombinant human IL-31 can be used together with HEK-Blue™ IL-31 cells for the screening of inhibitory molecules, such as Nemolizumab, a therapeutic monoclonal antibody targeting the IL-31Rα subunit of the IL-31 receptor (see figures).

 

Key features

  • Each lot is validated using HEK-Blue™ IL-31 cells
  • Endotoxin ≤ 0.1 EU/µg
  • 0.2 µm sterile-filtered

Applications

  • Standard for IL-31 detection and quantification assays
  • Screening and release assays for antibodies blocking IL-31 signaling
  • Screening and release assays for engineered IL-31

 

Interleukin-31 (IL-31) is a cytokine that plays a role in early protective inflammatory processes, likely regulating alarmins in damaged mucosal tissues. IL-31 is strongly involved in chronic inflammation in different skin diseases, including atopic dermatitis and allergic contact dermatitis.

more details More details

All InvivoGen products are for internal research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Source
E. coli
Species
Human
Accession sequence

Q6EBC2

Protein size
141 a.a. (S24-T164)
Carrier
Carrier-free
Tag
Tag-free
Purity
≥ 98% (SDS-PAGE)
Solubility

100 μg/ml in water

Formulation buffer

Phosphate buffer saline (pH 7.4)

Appearance (form)
Lyophilized
Reconstitution buffer
Endotoxin-free water (provided)
Sterility

0.2 µm filtration

Endotoxin

The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK‑Blue™ TLR4 cells.

Applications

Cellular assays (tested), ELISA

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    Recombinant human IL-31
  • Cat code: 
    rcyec-hil31
  • Quantity: 
    10 µg
Includes:

1.5 ml endotoxin-free water

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20°C
    Stability: -20°C for up to 6 months

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

IL-31 background

The cytokine interleukin 31 (IL-31) belongs to the Type I/II cytokine receptor family, and more specifically to the IL-6/gp130 family. IL-31 signals through a heterodimeric receptor comprised of the gp130-like subunit IL-31Rα and the OSMRb (oncostatin M receptor) subunit. The binding of IL-31 to its receptor triggers activation of the JAK/STAT, Akt/PI3K, and MAPK signaling pathways [1,2]. IL-31 receptor complex is expressed in epithelial, neuronal as well as immune cells. Little is known about the physiological function of IL-31. It is mainly secreted by IL-4-activated T cells, thereby contributing to Th2-weighted inflammation [1,2]. Several reports indicate that IL-31 is implicated in disorders such as atopic dermatitis, asthma, and inflammatory bowel disease [1,2]. Of note, IL-31 appears to be a critical cytokine involved in neuro-immune communication through the mediation of inflammatory itch [1,2]. Targeting the IL-31 pathway is a promising therapeutic option for dermatologic and non-dermatologic diseases with enhanced IL-31 expression [1,2].

 

References:

1. Bagci I.S. and Ruzicka, T., 2018. IL-31: A new player in dermatology and beyond. J. Allergy Clin Immunol. 141(3):858-866.
2. Datsi A., et al., 2021. Interleukin-31: The “itchy” cytokine in inflammation and therapy. Allergy. 76:2982-97.

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?